Cinnamic acid hybrids as anticancer agents: A mini-review.

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Cancer remains a leading global health challenge, with chemotherapy often failing due to multidrug resistance and severe side effects.
• Novel therapeutic strategies are urgently needed to improve cancer treatment outcomes.
• Cinnamic acid derivatives possess a unique chemical structure with demonstrated potential for anticancer activity.

Purpose of the Study:

• To provide a comprehensive review of cinnamic acid hybrids as anticancer agents.
• To explore the structure-activity relationships (SAR) of these compounds.
• To elucidate their diverse mechanisms of action against cancer cells.

Main Methods:

• Systematic literature review of research published between 2012 and 2021.
• Analysis of studies focusing on cinnamic acid derivatives and their anticancer properties.
• Evaluation of structure-activity relationships and mechanisms of action.

Main Results:

• Cinnamic acid derivatives represent a versatile scaffold for developing new anticancer drugs.
• These compounds exhibit diverse mechanisms, including cytotoxic effects, apoptosis induction, and anti-angiogenesis.
• Significant structure-activity relationships were identified, guiding the design of more potent agents.

Conclusions:

• Cinnamic acid hybrids hold considerable potential as novel chemotherapeutic agents.
• Further research into SAR and mechanisms can lead to effective anticancer drug development.
• These derivatives offer a promising avenue to overcome current chemotherapy limitations.